Yash Chemex (539939)
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹54.42 |
| Market Cap | ₹55.74 Cr |
| P/E Ratio | 27.73 |
| ROCE | 8.13% |
| ROE | 5.06% |
| Dividend Yield | 0% |
| Profit Growth | 200% |
| Debt/Equity | — |
| Sales Growth | 25.5% |
| 52-Week Range | ₹47.05 — ₹111 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹23.79 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹54.42, this is a small chemical trading company with a market cap of just ₹56 crore. Let's look beneath the surface. The reported profit growth of 200% and sales growth of 25.5% look impressive at first glance, but as Graham taught, one must examine the quality of earnings. The latest quarter shows net profit of only ₹1 crore on sales of ₹34 crore—a net margin of roughly 3%. That tells me this is a low-margin intermediary business, likely with little pricing power and no economic moat. ROE of just 5.06% and ROCE of 8.13% confirm that the company is not generating exceptional returns on capital. For a business with a P/E of 27.73, the market is paying a high multiple for earnings that could be volatile. The P/B of 2.29 means you are paying over twice book value, yet book value per share is only ₹23.79. While the Piotroski F-score of 7 suggests recent improvement in financial health, I must also note the zero dividend yield—I receive no cash while waiting. The PEG ratio of 0.25 looks tempting, but that is based on a 200% profit growth that is almost certainly unsustainable from a low base. Trading companies in chemicals face intense competition and cyclicality. I cannot call this a wonderful business. At best, it is a possible fast grower in an industry I generally avoid. I would need a margin of safety, and at 27 times earnings with returns on equity in single digits, I do not see it. The prudent approach is to watch from the sidelines.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer